Jaguar Gene Therapy spins out manufacturing with Deerfield, ARCH supportnews2024-01-17T13:00:01+00:00January 17th, 2024|Endpoints News|
Seagen’s infringement claims against Daiichi Sankyo denied by US patent officenews2024-01-17T12:23:00+00:00January 17th, 2024|Endpoints News|
Regenxbio touts positive mid-stage data for AbbVie-partnered vision-loss gene therapy, but no detailed plans for pivotal studynews2024-01-17T12:15:10+00:00January 17th, 2024|Endpoints News|
AstraZeneca reshuffles China leadership, sets up biopharma group to mirror global structurenews2024-01-17T12:03:15+00:00January 17th, 2024|Endpoints News|
Alpha Teknova lays off 15% of workforce, eliminates certain exec roles amid revenue downturnnews2024-01-17T11:58:49+00:00January 17th, 2024|Endpoints News|
Comanche secures $75M to test preeclampsia siRNA in PhII, adds Scott Gottlieb to boardnews2024-01-17T11:00:41+00:00January 17th, 2024|Endpoints News|
Lonza to shutter California mammalian clinical facility and lay off 218 staffersnews2024-01-17T10:31:45+00:00January 17th, 2024|Endpoints News|
Ravgen continues its legal revenge saga with a $57M verdict over Nateranews2024-01-17T08:51:05+00:00January 17th, 2024|Endpoints News|
Icahn ordered to remove lawsuit’s confidential information that was supplied by Illumina board membernews2024-01-17T00:25:15+00:00January 17th, 2024|Endpoints News|
Mental health tech unicorn SonderMind lays off 17% of its employeesnews2024-01-16T22:44:27+00:00January 16th, 2024|Endpoints News|
